1887

Abstract

Site-directed mutagenesis was used to study the biological significance of a disulphide bridge and two -linked oligosaccharides in the CD4-binding region of the envelope glycoproteins of human immunodeficiency virus type 1. Mutagenesis was performed in a phage M13 system at sites corresponding to the cysteine residue (amino acid 402) and the asparagine residues (390 and 447) of the gene. The mutated gene was inserted into a recombinant vaccinia virus under the control of the vaccinia virus 7.5K promoter and the expression of mutated proteins was analysed by SDS-PAGE, a conventional indirect immunofluorescence assay and by a fluorescence-activated cell sorter. Cysteine 402 was found to be essential for the specific cleavage of gp160 into gp120 and gp41, and for intracellular transport of the protein to the cell surface. CD4-binding and syncytium formation assays demonstrated that the disulphide bridge of cysteine 402 stabilized a conformation essential for receptor binding as well as syncytium formation by CD4 cells. No altered biological activity compared to that of the wild-type proteins could be detected for the mutant proteins lacking the -glycosylation sites. These data show that the two conserved glycans attached to asparagine residues 390 and 447 do not play any active role in the formation of the disulphide bridge involving cysteine 402 or in the maintenance of an active conformation of the protein, despite their location within the functionally important CD4-binding region.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-6-1269
1991-06-01
2024-12-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/6/JV0720061269.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-6-1269&mimeType=html&fmt=ahah

References

  1. Alexander S., Elder J. H. 1984; Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science 226:1328–1330
    [Google Scholar]
  2. Bischoff I., Kornfeld R. 1984; The effect of 1-deoxymannojiri-mycin on rat liver mannosidases. Biochemical and Biophysical Research Communications 125:324–331
    [Google Scholar]
  3. Bosch J. V., Tlusty A., McDowell W., Legler G., Schwarz R.T. 1985; The mannosidase inhibitors 1-deoxymannojirimycin and swainsonine have no effect on the biosynthesis and infectivity of Rous sarcoma virus. Virology 143:342–346
    [Google Scholar]
  4. Cheng-Myer C., Quiroga M., Tung J. W., Dina D., Levy J. A. 1990; Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. Journal of Virology 64:4390–4398
    [Google Scholar]
  5. Fenouillet E., Gluckman J. C., Bahraoui E. 1990; Role of N- linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. Journal of Virology 64:2841–2848
    [Google Scholar]
  6. Freedman R. B. 1989; Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins. Cell 57:1069–1072
    [Google Scholar]
  7. Freedman R. B., Bulleid N. J., Hawkins H. C., Paver J. L. 1989; Role of protein disulphide-isomerase in the expression of native proteins. Biochemical Society Symposia 55:167–192
    [Google Scholar]
  8. Gidlund M., Sydow M., Stenback A., Flodby P., Fossum H., Matsuda S., Lundin K., Wigzell H., Lind P. 1990; Production and characterization of a fragment containing the HIV-gpl20 binding region of CD4 using a bovine papilloma virus (BPV) vector. Archives of Virology 113:209–219
    [Google Scholar]
  9. Günalp A. 1965; Growth and cytopathic effect of rubella virus in a line of green monkey kidney cells. Proceedings of the Society for Experimental Biology and Medicine 118:85–90
    [Google Scholar]
  10. Hansen J. E., Clausen H., Nielsen C., Teglbjaerg L. S., Hansen L., Nielsen C. M., Dabelsteen E., Mathiesen L., Hakomori S.I., Nielsen J. O. 1990; Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gpl20may be a target for virus neutralization. Journal of Virology 64:2833–2840
    [Google Scholar]
  11. Hemming A., Lundberg L., Olofsson S. 1989a; A strategy simplifying site-directed mutagenesis in the CD4-binding region of HIV gpl20. Archives of Virology 107:301–305
    [Google Scholar]
  12. Hemming A., Bolmstedt A., Flodby P., Lundberg L., Gidlund M., Wigzell H., Olofsson S. 1989b; Cysteine 402 of HIV gpl20 is essential for CD4-binding and resistance of gpl20 to intracellular degradation. Archives of Virology 109:269–276
    [Google Scholar]
  13. Hu S.-L., Kosowski S. G., Dalrymple J. M. 1986; Expresson of AIDS virus envelope gene in recombinant vaccinia viruses. Nature, London 320:537–540
    [Google Scholar]
  14. Hurtley S. M., Bole D. G., Hoover-Litty H., Helenius A., Copeland C. S. 1989; Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP). Journal of Cell Biology 108:2117–2126
    [Google Scholar]
  15. Huso D. L., Narayan O., Hart G. W. 1988; Sialic acids on the surface of caprine arthritis-encephalitis virus define the biological properties of the virus. Journal of Virology 62:1974–1980
    [Google Scholar]
  16. Kieber-Emmons T., Jameson B. A., Morrow W. J. 1989; The gpl20-CD4 interface: structural, immunological and pathological considerations. Biochimica et biophysica acta 989:281–300
    [Google Scholar]
  17. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. 1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
    [Google Scholar]
  18. Kozutsumi Y., Segal M., Normington K., Gething M. J., Sambrook J. 1988; The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature, London 332:462–464
    [Google Scholar]
  19. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. 1987; Delineation of a region of the human immunodeficiency virus type 1 gpl20 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975–985
    [Google Scholar]
  20. Leonard C. K., Spellman M. W., Riddle L., Harris R. J., Thomas J. N., Gregory T. J. 1990; Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gpl20) expressed in Chinese hamster ovary cells. Journal of Biological Chemistry 265:10373–10382
    [Google Scholar]
  21. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. 1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348
    [Google Scholar]
  22. Matthews T. J., Weinhold K. J., Lyerly H. K., Langlois A. J., Wigzell H., Bolognesi D. P. 1987; Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gpl20 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proceedings of the National Academy of Sciences, U.S.A. 84:5424–5428
    [Google Scholar]
  23. Mizuochi T., Spellman M. W., Larkin M., Solomon J., Basa L. J., Feizi T. 1988; Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gpl20 produced in Chinese hamster ovary cells. Biochemical Journal 254:599–603
    [Google Scholar]
  24. Mizuochi T., Matthews T. J., Kato M., Hamako J., Titani K., Solomon J., Feizi T. 1990; Diversity of oligosaccharide structures on the envelope glycoprotein gpl20 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. Journal of Biological Chemistry 265:8519–8524
    [Google Scholar]
  25. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F., Wolf H. 1987; Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. Journal of Virology 61:570–578
    [Google Scholar]
  26. Nakamaye K. L., Eckstein F. 1986; Inhibition of restriction endonuclease Neil cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Research 14:9679–9698
    [Google Scholar]
  27. Ng D. T., Hiebert S. W., Lamb R. A. 1990; Different roles of individual iV-Iinked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Molecular and Cell Biology 10:1989–2001
    [Google Scholar]
  28. Pan Y. T., Hori H., Saul R., Sandford B. A., Molyneux R. J., Elbein A. D. 1983; Castanospermine inhibits the processing of the oligosaccharide portion of the influenza viral hemagglutinin. Biochemistry 22:3975–3984
    [Google Scholar]
  29. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R. Jr, Pearson M. L., Lautenberger J. A., Papas T. S., Ghayeb J., Chang N. T., Gallo R. C., Wong-Staal F. 1985; Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, London 313:277–284
    [Google Scholar]
  30. Rekosh D., Nygren A., Flodby P., Hammarskjöld M. L., Wigzell H. 1988; Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector. Proceedings of the National Academy of Sciences, U.S.A. 85:334–338
    [Google Scholar]
  31. Robey W. G., Arthur L. O., Matthews T. J., Langlois A., Copeland T. D., Lerche N. W., Oroszlan S., Bolognesi D. P., Gilden R. V., Fischinger P. J. 1986; Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope induces neutralizing antibodies. Proceedings of the National Academy of Sciences, U.S.A. 83:7023–7027
    [Google Scholar]
  32. Rossmann M. G., Johnson J. E. 1989; Icosahedral RNA virus structure. Annual Review of Biochemistry 58:533–573
    [Google Scholar]
  33. Saul R., Chambers I. P., Molyneux R. I., Elbein A. D. 1983; Castanospermine, a tetrahydroxylated alkaloid that inhibits β- glucosidase and β-glucocerebrosidase. Archives of Biochemistry and Biophysics 221:593–597
    [Google Scholar]
  34. Sjöblom I., Lundström M., Sjögren-Jansson E., Glorioso J. C., Jeansson S., Olofsson S. 1987; Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C. Journal of General Virology 68:545–554
    [Google Scholar]
  35. Stein B. S., Engleman E. G. 1990; Intracellular processing of the gpl60 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. Journal of Biological Chemistry 265:2640–2649
    [Google Scholar]
  36. Tarentino A. L., Maley F. 1974; Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus . Journal of Biological Chemistry 249:811–817
    [Google Scholar]
  37. Tarentino A. L., Plummer T. H. Jr, Maley F. 1974; The release of intact oligosaccharides from specific glycoproteins by endo-beta-N-acetylglucosaminidase H. Journal of Biological Chemistry 249:818–824
    [Google Scholar]
  38. Tschachler E., Buchow H., Gallo R. C., Reitz M. S. Jr 1990; Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope. Journal of Virology 64:2250–2259
    [Google Scholar]
  39. Walker B. D., Kowalski M., Goh W. C., Kozarsky K., Krieger M., Rosen C., Rohrschneider L., Haseltine W. A., Sodroski J. 1987; Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proceedings of the National Academy of Sciences, U.S.A 84:8120–8124
    [Google Scholar]
  40. Willey R. L., Bonifacino J. S., Potts B. J., Martin M. A., Klausner R. D. 1988; Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gpl60. Proceedings of the National Academy of Sciences, U.S.A 85:9580–9584
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-72-6-1269
Loading
/content/journal/jgv/10.1099/0022-1317-72-6-1269
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error